Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gynecology

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795228

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795228

Women's Healthcare

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Women's Healthcare Market to Reach US$12.1 Billion by 2030

The global market for Women's Healthcare estimated at US$9.7 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Hormonal Infertility Application, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Postmenopausal Osteoporosis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 6.8% CAGR

The Women's Healthcare market in the U.S. is estimated at US$2.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Women’s Healthcare Market - Key Trends & Drivers Summarized

Why Is Women’s Healthcare Emerging as a Distinct and Prioritized Sector in Global Health?

Women’s healthcare is rapidly evolving as a specialized domain within the broader healthcare ecosystem, reflecting the growing awareness that women have unique physiological, hormonal, and reproductive health needs across different life stages. Unlike traditional healthcare models that often generalized treatments for both genders, modern medicine increasingly recognizes the importance of gender-specific diagnostics, treatments, and preventive care. The prioritization of women’s health stems from a history of underrepresentation in clinical research and systemic neglect, which has led to misdiagnoses and suboptimal care for female patients. Today, governments, healthcare providers, and global organizations are placing a stronger emphasis on addressing these disparities by tailoring services that focus on menstrual health, fertility, pregnancy, menopause, breast and gynecological cancers, osteoporosis, and autoimmune diseases, among others. Social movements and advocacy efforts have brought attention to issues like endometriosis, postpartum depression, and contraceptive access, prompting better policy responses and funding allocation. In addition, an aging female population worldwide is increasing demand for chronic disease management related to cardiovascular health, bone density, and hormone regulation. By recognizing that women’s healthcare needs extend far beyond reproductive care, the medical community is taking steps to develop a more comprehensive and equitable system that ensures timely, accurate, and gender-sensitive care for women of all ages and backgrounds.

How Are Technological Innovations Revolutionizing the Women’s Healthcare Landscape?

Technology is playing a transformative role in reshaping the women’s healthcare landscape, making care more personalized, accessible, and data-driven. One of the most impactful developments is the proliferation of digital health tools such as mobile apps, wearable devices, and telehealth platforms that enable women to track their menstrual cycles, monitor pregnancy progress, access contraception advice, and manage chronic conditions from the comfort of their homes. Fertility tech, including ovulation trackers and AI-assisted in vitro fertilization (IVF) platforms, is empowering women with more control over their reproductive timelines. Diagnostic technologies have also improved, enabling earlier detection of diseases such as breast and ovarian cancer through advanced imaging and genetic testing. Remote consultations have become especially important in rural and underserved areas, where women often face barriers related to mobility, stigma, or lack of nearby specialists. In addition, electronic health records and predictive analytics are helping clinicians tailor treatment plans based on individual patient profiles, improving outcomes in areas like hormonal therapy and prenatal care. Startups and femtech companies are leading the charge by developing innovative solutions such as non-invasive diagnostics, digital pelvic floor trainers, and mental health platforms that cater specifically to women’s unique needs. These innovations are not only enhancing clinical care but also breaking down longstanding taboos and promoting a culture of health empowerment, allowing women to take an active role in their well-being with unprecedented ease and confidence.

What Societal Shifts and Policy Changes Are Influencing the Women’s Healthcare Market?

Societal awareness and policy reforms are playing an increasingly important role in shaping the direction and momentum of the women’s healthcare market. Around the world, women are demanding better access to quality healthcare, equal representation in clinical research, and stronger protections against health inequities, leading to more robust public discourse and legislative action. Governments and health agencies are enacting policies to expand coverage for maternal care, fertility treatments, contraception, and cancer screenings, often under broader gender equality or universal healthcare frameworks. The global conversation around menstrual equity is prompting institutions to provide free sanitary products and education, helping dismantle the stigma that surrounds menstruation. Additionally, the rising visibility of women’s mental health challenges, including postpartum depression and anxiety disorders, is prompting a shift toward more inclusive and integrated mental healthcare services. Insurance providers are also beginning to include more comprehensive women’s health benefits, reflecting market demand for better preventive care and long-term wellness solutions. Media and advocacy campaigns continue to amplify the voices of those affected by chronic yet underdiagnosed conditions such as polycystic ovary syndrome (PCOS), fibroids, and perimenopause symptoms, prompting the medical community to invest in research and education. These societal and regulatory shifts are not only improving access to care but also reshaping cultural narratives around female health, affirming that women’s medical concerns are both valid and deserving of systemic support. The result is a more informed, engaged, and empowered patient base that expects healthcare systems to evolve in step with their needs.

What Is Driving the Global Growth and Long-Term Potential of the Women’s Healthcare Market?

The growth in the women’s healthcare market is driven by a confluence of demographic, technological, economic, and sociopolitical factors that together underscore the importance and urgency of investing in gender-specific health solutions. One of the primary drivers is the rising global female population coupled with increased life expectancy, which is resulting in higher demand for long-term care related to aging, hormonal changes, and chronic illness management. Economic empowerment and higher educational attainment among women are also contributing to a more health-literate consumer base that actively seeks preventive care and personalized treatment options. The increasing availability and affordability of health technologies, from fertility diagnostics to telemedicine platforms, are expanding access and enabling earlier interventions, particularly in emerging economies where healthcare infrastructure is improving rapidly. Venture capital investment in femtech and women-centric health startups is infusing the market with innovation and helping address historically neglected areas. In parallel, multinational pharmaceutical companies are launching new therapeutics tailored to conditions affecting women, from hormone therapies to targeted cancer treatments. Regulatory bodies are responding by streamlining approval pathways for female-specific drugs and devices, further accelerating market development. Corporate wellness programs and workplace health initiatives are also beginning to recognize and address women’s unique health challenges, fostering better health outcomes and productivity. These interconnected drivers reflect a sustained commitment to closing the gender gap in healthcare, ensuring that women receive the attention, research, and medical advancements long overdue. The trajectory of the women’s healthcare market points toward continued global expansion, supported by a growing awareness that empowering women’s health is foundational to the well-being of families, communities, and economies.

SCOPE OF STUDY:

The report analyzes the Women's Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Ava Women
  • Besins Healthcare
  • Bonzun
  • Duchesnay
  • Flo Health
  • Lilly (Eli Lilly)
  • Mayne Pharma
  • Medicines360
  • Midi Health
  • Morgan Stanley Inclusive Lab
  • Natural Cycles
  • Organon
  • Pfizer
  • Pristyn Care
  • Roche
  • Ru Medical (Unpause)
  • Sanofi

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38401

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Women's Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Gender-Specific Health Needs Throws the Spotlight on Women's Healthcare as a Global Priority
    • Shift Toward Preventive Care Models Spurs Demand for Early Diagnosis and Screening Services Across Female Health Conditions
    • Here's How Digital Health Platforms Are Expanding Access to Reproductive and Menstrual Health Management
    • Increased Focus on Maternal Health and Safe Childbirth Strengthens the Business Case for Integrated Prenatal Care Solutions
    • Investment in Fertility Services and Egg Freezing Expands the Addressable Market Opportunity in Reproductive Technologies
    • Aging Female Population and Menopause Management Drive Innovation in Hormone Therapy and Lifestyle Interventions
    • Rising Mental Health Awareness Among Women Fuels Demand for Gender-Sensitive Therapy and Support Programs
    • Here's How FemTech Startups Are Disrupting Traditional Care Models with Personalized, App-Based Solutions
    • Growth in Gynecological Oncology Screening and Treatment Accelerates Adoption of Advanced Diagnostics and Surgical Tools
    • Workplace Wellness Programs and Corporate Benefits Support Expansion of Holistic Women-Centered Care Offerings
    • Access to Contraceptive Options and Family Planning Services Sustains Progress in Reproductive Autonomy and Choice
    • Global Rise in Polycystic Ovary Syndrome (PCOS), Endometriosis, and Autoimmune Disorders Highlights Unmet Needs in Women's Health
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Healthcare Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hormonal Infertility Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Postmenopausal Osteoporosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Endometriosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Contraceptives Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Menopause Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Polycystic Ovary Syndrome Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Women's Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: France 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Women's Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 74: India Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: India 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Women's Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Women's Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!